TVM Capital Life Science - Portfolio Partners Reviews News
TVM Capital Life Science
TVM Capital Life Sciences is one of the pioneers of transatlantic venture capital based in North America and Europe. News
Portfolio References Employees: 1-10 Investment type: Venture capital Investment stage: Series C Investment datePortfolio 27
| Company name | Website | Total amount raised | Location | 01. 02. 2023 |
| Albireo Fa | Albireo Fa | $24 million | United | 04. 03. 2021 |
| Access Bus | Access Bus | $51 million | US | 04. 03. 2021 |
| Kent Imagine | Kent Imagine | $15 million | Canada | 05. 03. 2019 |
| Emovie | emovi. | $11, $23 million | Canada, Mo. | CoLucid Ph. |
| - | CoLucid. | $44, $6 million | US | 04. 03. 2021 |
| - | F-star Com | $46, €16 million | UK | Inbend Me |
| - | Inbend Me | 2, 800 $39 million | Concert Ph. | - |
| - | Concerta | $127 million | - | - |
| - | United Sta. | Acer Thera. | acertx. | - |
| - | $56 million | US | Probio Drug | 04. 03. 2021 |
| - | 19, 41 mn | Strongbride | Strong Group | 04. 03. 2021 |
| - | Rapid Micro | Rapid Micro | $293 million | - |
| - | United Sta. | Prichidenta | Prichidenta | - |
| - | Germany, B. | Leon-Nanod | leon-nanod. | 04. 03. 2021 |
| - | Germany, B. | Evotec | - | Evotec. com |
| - | $513 million | $513 million | Protaras | Evotec. com |
| - | Germany, X. | Specpharm H. | Spefarm C. | Netherlands |
| - | Avionix | Avionix | - | 04. 03. 2021 |
| - | NOXXON Pha. | NOXXON. | - | $66, €34 million |
| - | Direvo AG | Direvo. com | - | Germany, N. |
| - | DEINOVE. | France, Oc. | Biovertis. | - |
| - | Morphochem. | Czech Republic, P. | - | Bluebird B. |
| - | bluebirdbi. | $90 million | - | Germany, N. |
| - | Panthera D. | Panthera | - | Canada, California |
| - | Central | Sentigene | $28, 02 mn | 04. 03. 2021 |
| - | More | Date | - | Title |
| - | Content | 20. 07. 2023 | Tillotts Pharma and TVM Capital Life Sciences Announce Partnership | Mage Biologics Develops Monoclonal Antibody Targeting Ulcerative Colitis Develops Novel Specific Antibody |
News 308
| Company name | Montreal, Canada/Munich, Germany - March 17, 2023 - TVM Capital Life Sciences ("TVM") is pleased to announce that it will exhibit at LSI USA '23 Emerg. | 23. 02. 2023 |
| TVM Capital Life Sciences Announces Offer to Increase Visibility for S. M. S. | Montreal, Canada/Munich, Germany - February 2, 2023 - TVM Capital Life Sciences ("TVM") will exhibit at LSI USA '23 Emerg. S. A. February 23, 2023 - TVM Capital Life Sciences ("TVM") has announced that it has acquired S. A., a leading global life sciences company headquartered in Montreal, Canada. | 21. 02. 2023 |
| Esperas Pharma Announces TVM Life Sciences Investment | Montreal, Quebec, February 21, 2023 - Montreal-based Esperas Pharma, Inc. | 08. 02. 2023 |
| TVM Capital Life Sciences Announces Investment in LAmAb Biologi. | LAmAb Biologics Develops First-in-Class Monoclonal Antibody for Preventive Therapeutic Targeting of IgE. | 01. 02. 2023 |
| TVM Capital Life Sciences Announces Investment of Up to $24 Million USD | Recurv is TVM Life Science Innov's eighth early stage or product-focused company (PFC) investment. | 18. 12. 2022 |
| TVM Capital Winter Conference | Dear partners at TVM Capital Life Sciences, we have decided to cancel TVM Winte 2023. | 01. 08. 2022 |
| Albireo Fa | July 28, 2022, Quebec, Canada Panthera Dental, a global leader in CAD/CAM implants, has acquired Panthera Dental, a global leader in CAD/CAM implants, on July 28, 2022. | 23. 06. 2022 |
| Kent Imaging recognized as the most innovative medical imaging system. | Snapshotnir enables clinicians to achieve better treatment outcomes in wound care, limb salvage and SU. | 29. 03. 2022 |
| Egg Medical Hatches Technology to Protect Healthcare Workers | Arden Hills secures $13 million in funding. Burl Gilyard Star Tribune March 27th issue. | 15. 03. 2022 |
| Egg Medical secures $13 million in VC funding | March 4, 2022 By Annette Boyle Egg Medical has secured a $13 million investment from TVM Capita. | 03. 03. 2022 |
| Egg Medical closes $13 million in funding | Egg Medical closes $13 million in funding Arden Hills, Minnesota (March 3, 2022) - Egg Medical... | 08. 02. 2022 |
| Centogen announces Miguel's transfer and appointment. | CAMBRIDGE, MA & ROSTOCK (GERMANY), BERLIN, 8 FEBRUARY 2022 (Globe Newswire - Centogene N. V. | 01. 02. 2022 |
| Centogen announces the appointment of Andreas Busch as Supervisor. | Cambridge, MA & ROSTOCK (GERMANY), BERLIN, 1 FEBRUARY 2022 (Globe Newswire - Centogene N. V. | 01. 02. 2022 |
| Centogen announces the appointment of Kim Stratton as Chief Executive Officer. | Cambridge, MA & ROSTOCK (GERMANY), BERLIN, 1 FEBRUARY 2022 (Globe Newswire - Centogene N. V. | 01. 02. 2022 |
| Centogen announces $62 million in total equity and debt proceeds. | Cambridge, MA & ROSTOCK (GERMANY), BERLIN, 2 FEBRUARY 2022 1 (Globe Newswire - Centogene N. V. | 18. 01. 2022 |
| Centogen announces $62 million in total equity and debt proceeds. | Munich, Germany/Montreal, Canada - January 12, 2022 - TVM Life Sciences ("TVM") has promoted Dr. Sascha Berger and Dr. | 18. 01. 2022 |
| Centogen announces $62 million in total equity and debt proceeds. | Luxembourg, January 13, 2022 - TVM Life Sciences Innovation II SCSP announces the investment of the fund. | 18. 01. 2022 |
| Acer Therapeutics to raise $3. 2 billion in third-quarter 2021 funding Announces Quarterly Financial Results and Provisionals | Newton, MA - November 19, 2021 - Acer Therapeutics, Inc. (NASDAQ: ACER) announced its third quarter 2021 financial results. | 16. 11. 2021 |
| Kent Imaging - Setting a new global standard for advanced TIS. | 16 November 2021 Kent Imaging is the market leader in light-based tissue diagnostics. | 16. 11. 2021 |
| Nekonal and TVM Capital Life Science announce the formation of T7. | Luxemburg, November 15, 202 1-TvM Life Science Innovation II SCSP has announced funds. | 08. 10. 2021 |
| Acer Serapytics receives compensation notifications from Key You Es Pee | Nippon Acer Co., Ltd. (Headquarters: Shinjuku-ku, Tokyo; President and CEO: 詹 Kuni (Bob Sen), hereinafter referred to as "Acer") has received notifications on compensation for the compensation of ACER-001 for the company's patent application. Was announced. | 08. 10. 2021 |
| Acer Serapytics receives compensation notifications from Key You Es Pee | Cambridge, Massachusetts and Rostock (Germany), Berlin, South San Francisco (California), October 06, 2021 (GLO. | 15. 07. 2021 |
| Rapid Micro BIOSYSTEMS has announced the price decision of new stocks. | Source: Rapid Micro BIOSYSTEMS, Inc. July 14, 2021 9:30 pm (Eastern the United States), Rowel, Massachusetts (GLOBE NEWS. | 27. 05. 2021 |
| Rapid Micro BIOSYSTEMS has announced the price decision of new stocks. | Newton, Massachusetts and Genev a-May 25, 202 1-Acer Seraputics (Headquarters: Rowel, Massachusetts, NASDAQ: ACER, hereinafter "Acer") was ACE R-001 in the third quarter of 2021 We plan to apply for a new drug approval. | 25. 03. 2021 |
| Cobit Innovations March 25, 2021 | The author March 25, 2021 Imagine a pandemic occurs without stopping your life. | 22. 03. 2021 |
| Acer THERAPEUTICS and a license agreement concluded a license agreement. | RELIEF may pay up to $ 36 million to Acer, and in exchange for net income. | 04. 03. 2021 |
| Access Vascular, Inc. secures $ 20 million in Series B | Bedford, Massachusetts-March 3, 2021-Access Basculer Ink is a company targeting the highest cost reduction. | 25. 02. 2021 |
| Kent agreed with net health and expanded the footprint of snapshots | David Godkin, STAFF WRITER Toront o-Please think about it. 98%of facilities exceeding 14. 000 have medical insurance. | 01. 02. 2021 |
| Access Bus | Luxembourg, February 1, 202 1-TVM Life Science Innovation II SCSP today announced an investment in a global medical device manufacturer. | 01. 02. 2021 |
| TvM Life Science Innovation II SCSP announces investment in Luxembourg | Luxembourg, February 1, 2021 --TVM Life Science Innovation II SCSP is a fund's incubation today ... | 19. 01. 2021 |
| TvM Life Science Innovation II SCSP announces investment in Luxembourg | Luxembourg, January 19, 202 1-TVM Life Science Innovation II SCSP today announced an investment in the fund. | 14. 01. 2021 |
| TvM Life Science Innovation II SCSP announces investment in Luxembourg | Luxembourg, January 19, 202 1-TVM Life Science Innovation II SCSP today announced an investment in the fund. | 07. 01. 2021 |
| EMOVI and SIAWARDS: Interviews on Kneekg and knee pain | Luxembourg, January 19, 202 1-TVM Life Science Innovation II SCSP today announced an investment in the fund. | 13. 11. 2020 |
| Kent Imagine | (Charlotte/ Quebec, November 12, 2020) The dentist has now gained the opportunity to use PrimeScan with new A. | 27. 10. 2020 |
| TVM Capital Life Science basically announces ove r-script. | Munich/ Montreal: October 27, 2020-TVM Capital Life Science is a major venture life science ... | 22. 10. 2020 |
| Sentgen announces the change of management | Cambridge Sentgen, Massachusetts (Cambridge, Massachusetts, German Rostock, Berlin): October 20, 2020 (Globe News Wire) | 15. 07. 2020 |
| St. Jen announces primary and secondary audience prices | Cambridge, Cambridge, Cambridge, Rostock (Germany), Berlin (Germany), July 9, 2020 (Globe Newswire) -centogene N. V. | 10. 07. 2020 |
| Cambridge, Germany, Germany, and Berlin, Germany, USA. | Cambridge, Massachusetts and Rostock (Germany), Berlin, July 7, 2020 (Globe Newswire) --Sentgen (N. | 08. 04. 2020 |
| Sentgen opened a Corona test lab | Christmas is a lucky day: Companies with Rostock, experienced serious illness in just a few years | 03. 04. 2020 |
| Quebec City's Pantera employees worked hard. | (Montreal, March 24, 2020) 3D printing companies are actively working on fighting. | 24. 03. 2020 |
| St. Jen announces the start of clinical trials of COVID-19 | Cambridge & Amp; German Rostock/ Berlin March 18, 2020 (Global Newswire) --Sentgen (NASD. | 04. 02. 2020 |
| La Presse: "Laurent Duberne t-Tardif's knee is the best condition. | "With no injuries during Sunday games, Laurent Duberne t-Tardi's knees would be stable. | 15. 11. 2019 |
| Sentgen concludes data access and partner agreements | New treatment of rare diseases due to partner contracts accelerated Cambridge & Amp; Ro. | 08. 11. 2019 |
| Sentgen AG C. | 29. 10. 2019 | Sentgen announces new shares of Common Communications |
| October 28, 2019 8:53 am. EDT Massachu Setts Cambridge and Rostock, Germany, Octover 28, 2019 (GLOBE NEWSWIR. | 18. 10. 2019 | NEURIMMUNE and TVM Capital Life Science have announced a joint venture with TVM Capital Life Science in Switzerland. |
| Switzerland, Shurelen-October 16, 201 9-Al-S Pharma AG was jointly established and Fi. | 14. 10. 2019 | - |
| Lily's Reyvow ™ (Lasmiditan) is the first and only drug. | Reyvow approval is important because it is the first new classic migraine treatment. | 02. 10. 2019 |
| EMOVI has announced the results of clinical trials on knee joint management. | The result is that the use of kneekg for patients with knee osteoarthritis reduces pain and improves knee osteoarthritis. | 25. 09. 2019 |
| Serapyutics and Altara Therapytics agree to the merger | 2019/09/23 TransArc to launch rare and specialty disease treatment NASDAQ | 17. 09. 2019 |
| Bio Deutschland - Biotechnology Industry Association Selects Dr. Hu | Berlin (September 17, 2019) - THE BOCKENVERBAND DER BIOTECHNOLOGIE-INDUSTRIE, BIO DEUTSCHLAND e. V... | 24. 06. 2019 |
| We are very proud to be the recipient of the 201st annual award. | The Canadian Venture Capital and Private Equity Association (CVCA) has announced the winners of the Canadian Venture Capital and Private Equity Association Awards. | 28. 05. 2019 |
| Centogen Welcomes German Chancellor Angela Merkel. | Centogen welcomes German Chancellor Angela Merkel to its headquarters on May 23, 2019. | 02. 04. 2019 |
| CentGen announces the appointment of Dr. Flemming Ornskov. | Rostock/Berlin, Germany, April 2, 2019 - CentGen today announced that Dr. Flemming Ornskov has been retained. | 04. 03. 2019 |
| EMOVI Accelerates Growth with Series C$ Investment | Photo by EMOVI MONTREAL, March 4, 2019 / CNW Telbec / - EMOVI today announced a partnership with TVM. | 02. 01. 2019 |
| Please use our dedicated page for funding requests! | To ensure that your funding requests are processed in a timely manner, we have added a new page to our website. Please take advantage of it. | 17. 10. 2018 |
| 1st Tirol Biotech Conference (Umit): "The Future of Life Sciences" | Einzigartige Πρωτοβουλία from Private Risikokapital and Öffentlicher Χειρόχρωρχromo Χειρόχromo Beteiligung des Landes. | 03. 10. 2018 |
| CentGen and Denali Therapeutics Announce Strategic Alliance | CentGen and Denali Therapeutics (NASDAQ: DNLI) today announced a strategic alliance in the development of cancer drugs. | 07. 06. 2018 |
| F-Star Announces Early Exercise by Denali Therapeutics | Cambridge, UK, May 30, 2018 - F-Star has announced that it has received a new BIS Aurka Pharma is a clinical-stage biopharmaceutical company developing a treatment for cancer. | 14. 05. 2018 |
| Lilly Acquires Aurka Pharma | The acquisition expands Lilly's oncology pipeline with early-stage assets being studied in multiple T tumors. | 08. 05. 2018 |
| Rapid Micro Biosystems secures $60 million in equity financing. | The investment will accelerate the company's ongoing global commercial expansion and cost-effectiveness. | 13. 04. 2018 |
| Deinove Acquires Biovertis/morphochem | Deinove gains access to Biovertis/Morphochem MCB3837, a potential therapeutic agent. | 19. 03. 2018 |
| Prof. Arndt Rolfs joins recently launched "E. G. C. Global Committee" | Arndt Rolfs of Centogene AG Recently, Professor Rolfs, a member of the Global Commission to End Diagnosti. | 13. 11. 2017 |
| Norgine Ventures closes €2 million in Pritide. | London, UK. 7 November 2017, 08:35am. Norgine Ventures today closed a Fin. | 05. 11. 2017 |
| See you at Bio-Europe! | We are Bio-Europe sponsor this year to be held in Berlin from November 25 (Monday). | 25. 10. 2017 |
| TVM Capital Life Science has sold Invendo Medical Gmbh. | Denmark Varelap and Germany Kiss, October 25, 201 7-Leader in Growth, today. | 04. 10. 2017 |
| Pantera Dental accelerates growth through investment | Quebec City, October 3, 2017 Panthera Dental today announced the current relationship with TVM Life Science V. | 20. 09. 2017 |
| TVM Capital Life Science will hold the 6th Life Science C. | Montreal, September 19, 2017, TVM Capital Life Science held the 6th Annual Autumn Conference. | 04. 07. 2017 |
| Acer Therapeutics and Opexa Therapeutics signed the merger. | This merger will create a pr e-NDA pharmaceutical company specializing in new drug development. | 23. 06. 2017 |
| Proteon Therapeutics announced a thir d-party allotment of $ 22 million. | Supply Waltham, Mass. | 13. 06. 2017 |
| Sentgen raises a 25 million dollar series A fund for fuel | June 13, 2017, Centogene AG, a global leader of Gene Diagnosis, on June 13, 2017. | 04. 06. 2017 |
| Proteon of treatment receives Desig Breakthrough Therapy | Walosum (Massachusetts) May 10, 2017 (GLOBE NEWSWIRE) --PROTEON THERAPEUTICS, Inc. | 17. 05. 2017 |
| Fascinating for investors! Spetressed Medicine is Sho. | Many VC investments and their novelty in the life science field are implicit Inbe. | 09. 05. 2017 |
| Noxon Pharma has a 1 million euros a thir d-party assignment increase | Germany, Berlin, May 2, 201 7-Biotechnology company NOXXON Pharma N. V. (Alternext PARIS: ALNOX). | 23. 03. 2017 |
| Lilly and Corside Pharmaceuticals have announced Lil's acquisition agreement. | With $ 960 million transactions, Lily's existing migraine pain management portfolio will be enhanced. Add Potenti. | 09. 01. 2017 |
| Leon has appointed pharmacy expert Michael Mailer as the highest executive officer | Leon Nano Drugs GMBH has appointed pharmaceutical expert Michael Mailer (SC. D.) as a new highest executive officer. | 07. 12. 2016 |
| NEURIMMUNE and TVM Capital Life Science have announced their establishment. | Shrielene (Switzerland) and Munich (Germany) December 7, 2016 / B3C Newswire / --Neurimmune and TVM. | 05. 12. 2016 |
| Pfizer Ventures and TVM Life Science Ventures VII A. | London (Britain), December 5, 2016 / -Fisor Venture Investments (PVI) and TVM Life Science Ventures VII. | 05. 12. 2016 |
| Noxon Pharma publishes a new pr e-clinical data that shows synergistic effects | Inhibition of CXCL12 by poster title NOX-A12 (OlapteedPegol) coordinates with CD ADCC activity. | 04. 11. 2016 |
| Completed a transaction with Albileo and Biodel and published stocks | November 3, 2016 --Albireo Pharma, Inc. trades with the "Albo" symbol in Nasdaq Capital Market. | 04. 11. 2016 |
| Completed a transaction with Albileo and Biodel and published stocks | Cologne Session Date: November 7, 2016 Time: 16: 00-17: 00 Flow: Main Agenda, Level | 19. 09. 2016 |
| TVM Life Science Ventures VII has announced investment in AURKA. | On September 19, 2016, Montreal, Quebe c-TVM Life Science Ventures VII today announced the fund's TWE. | 07. 09. 2016 |
| TVM Life Science Ventures VII has announced investment in AURKA. | Simple and safe and effective solution for cros s-pollution and infection control issues. | 06. 09. 2016 |
| Corside Pharmaceuticals, Primary (PRIMAR. | Cambridge, Massachusetts, September 6, 2016 --Colucid Pharmaceuticals, Inc. | 10. 08. 2016 |
| Corside Pharmaceutical announces its performance in the second quarter of 2016 | Cambridge, Massachusetz-August 10, 2016-Corside Pharmaceuticals Ink (NASDAQ) reported on funding today. | 25. 07. 2016 |
| FDA has given MCB3837, QiDP and fast track designation to morphokem | Munich (Germany), July 25, 2016-Morfokem, a clinical pharmaceutical company, is toD. | 22. 06. 2016 |
| Morphokem New Drug (IND) ACCE clinical trial application. | Munich (Germany), June 22, 2016-Morfokem, a non-listed pharmaceutical company in the clinical stage, announced. | 21. 06. 2016 |
| TVM Life Science Ventures VII announces investment in the Medity | On June 20, 2016, Montreal, Quebe c-TVM Life Science Ventures VII closed the 11th fund investor. | 09. 06. 2016 |
| Corside Pharmaceuticals announces that it has randomly assigned the latest patients | Cambridge (Massachusetts) June 7, 2016 (GLOBE NEWSWIRE) -Corside Pharmaceuticals Ink (NASDAQ: CLCD) | 27. 05. 2016 |
| Biodel ink and Albileo Limited agree to the merger | May 24, 2016 Conference Call May 25, 2016 (Wednesday) 8:30 am et danbury, ct and boston, ma. | 27. 05. 2016 |
| Corside Pharmacyut Chard announces the start of phase II | Cambridge (Massachusetts) May 19, 2016 (GLOBE NEWSWIRE) -Corside Pharmaceuticals, Inc. | 14. 04. 2016 |
| Esperas Pharma Co., Ltd. will start clinical development of new drugs. | On April 11, 2016, Montreal, Quebe c-Esperas Pharma Inc. (hereinafter "Esperas") announced today. | 02. 03. 2016 |
| Esperas Pharma Co., Ltd. will start clinical development of new drugs. | Cambridge, Massachusett s-March 1, 2016 --Colucid Pharmaceuticals, Inc. | 01. 02. 2016 |
| TVM Life Science Ventures VII announces investment in Modula | On February 1, 2016, Montreal, Quebe c-TvM Life Science Ventures VII today announced the ninth fund. | 25. 01. 2016 |
| TVM Capital Life Science Investment Company IXCHELSIS LTD ANN. | January 25, 201 6-Sandwich, UK. -IXCHELSIS LTD, a U K-based biotechnology company, announced today. | 11. 12. 2015 |
| See the Bio-Europe session on external innovation strategies. | One of the most popular discussions in this year's Bio-Europe, mode ... | 23. 09. 2015 |
| Carlos J. Reitao, the Minister of Finance, Quebec, holds Kino. | On September 22, 2015, Montreal, Quebe c-TVM Capital Life Science held the 4th TVM C. E. E. yesterday. | 27. 07. 2015 |
| LEON-NANODRUGS GMBH raises 18. 5 million euros in the final round of Series A. | TVM Capital Life Science led an international investor syndicate and added more than 3 million euros. | 17. 07. 2015 |
| ARGOS THERAPEUTICS has announced the completion of the patient registration. | Evaluate completely individualized immunotherapy in combination with standard target therapy | 15. 06. 2015 |
| Provio Drug won the 2015 European Best Medison Award | On June 12, 2015, HALLE/SAAL E-Probio Drug AG (Euroneext Amsterdam) is a biopharmaceutical company. | See more |
| date | title | overview |
| sauce | 31. 01. 2024 | TVM Capital Life Science announces 8 million euros investment on . NET |
Mentions in press and media 22
| Company name | Montreal, Canada/Munich, Germany - March 17, 2023 - TVM Capital Life Sciences ("TVM") is pleased to announce that it will exhibit at LSI USA '23 Emerg. | 23. 02. 2023 | Fins Corporation |
| 01. 02. 2023 | TvM Capital Life Science announced an investment of up to $ up to $ 24 million. | - | RECURV is the eighth early stage or produc t-specific company (PFC) investment for TVM Life Science Innov. |
| TVM-LifeSc. | 01. 02. 2023 | TvM Capital Life Science announced an investment of up to $ up to $ 24 million. | Globenewsw. |
| Albireo Fa | July 28, 2022, Quebec, Canada Panthera Dental, a global leader in CAD/CAM implants, has acquired Panthera Dental, a global leader in CAD/CAM implants, on July 28, 2022. | 23. 06. 2022 | EinPresswi. |
| Albireo Fa | July 28, 2022, Quebec, Canada Panthera Dental, a global leader in CAD/CAM implants, has acquired Panthera Dental, a global leader in CAD/CAM implants, on July 28, 2022. | - | RECURV is the eighth early stage or produc t-specific company (PFC) investment for TVM Life Science Innov. |
| Albireo Fa | July 28, 2022, Quebec, Canada Panthera Dental, a global leader in CAD/CAM implants, has acquired Panthera Dental, a global leader in CAD/CAM implants, on July 28, 2022. | Venture fund has launched an antibody biotech in Delaware CRO Cha. | On Monday, Luxembourg's venture fund has announced an unreleased investment. |
| ENDPTS. | 18. 03. 2021 | Tvm Capital Healthcare, 2 $ 500 million in two target funds | Premium TVM Capital Healthcare (TVMCH), the UAE category of German investment company TVM capital, is raising funds. |
| Decorbound | 14. 01. 2021 | Kent Imaging accelerates growth in US $ 15 | Calgary (AB), Canada, January 13, 2021 / Einpresswire. com/ -Kent Imaging, Inc. |
| TVM-LifeSc. | 28. 10. 2020 | TvM Capital Life Science Close the 2nd fund of $ 478 million | The TvM Capital Life Science logo TVM Capital Life Science is based in Munich, Germany and Montreal. |
| Kent Imagine | (Charlotte/ Quebec, November 12, 2020) The dentist has now gained the opportunity to use PrimeScan with new A. | 27. 10. 2020 | EinPresswi. |
| TVM-LifeSc. | 27. 10. 2020 | TVM Capital Life Science basically announces over subscriptions. | Globenewsw. |
| St. Jen announces primary and secondary audience prices | Cambridge, Cambridge, Cambridge, Rostock (Germany), Berlin (Germany), July 9, 2020 (Globe Newswire) -centogene N. V. | 10. 07. 2020 | EinPresswi. |
| St. Jen announces primary and secondary audience prices | Cambridge, Cambridge, Cambridge, Rostock (Germany), Berlin (Germany), July 9, 2020 (Globe Newswire) -centogene N. V. | Betakit. | |
| EMOVI has announced the results of clinical trials on knee joint management. | NEURIMMUNE spins off AL-S Pharma | Startup | |
| Emovie | Daily fund procurement updat e-July 27, 2015 | Palunity received $ 450 million. Draft Kings added $ 300 million. Secret Escape acquires $ 60 million BUYATAB Online Inc, A V. | vator. TV/n. |
| 16. 04. 2015 | Esperas Pharma receives VC investment | Startup | |
| Provio Drug won the 2015 European Best Medison Award | 08. 10. 2014 | TvM Capital Life Science Close the fund with $ 21 million | TvM Capital Life Science, a global life science venture capital, has closed the latest funds of $ 21 billion. |
| FINSMES. | 06. 10. 2014 | TvM Capital Life Science Closes a $ 21 million and $ 6 million fund | Globenewsw. |
| 06. 10. 2014 | Tvm Capital Life Science Close Fund VII for $ 2. 20 million | Venturecap. | Globenewsw. |
| TvM Capital Life Science has succeeded in two biotechnology IPOs. | On February 19, 2014, Munich, Montrea l-Biotechnology IPOs are continuous and have a clear joy. | - | TVM-LifeSc. |
| TvM Capital Life Science has succeeded in two biotechnology IPOs. | Kaneq BIOSCIENCE receives investment from TVM Life Science V. | - | TVM-LifeSc. |
| Finzume Co., Ltd.. | See more | Sign up and leave a review | EinPresswi. |
| Globenewsw. |
Reviews 0
In was created TVM Capital Life Science, which is appeared as VC. The venture was found in Europe in Germany. European life sciences firms are particularly attractive targets for larger private equity firms because of their focus on pharma discovery. Great news! Biosimilar ranibizumab recently launched in Source: Healthcare & Life Sciences Review, Pharma Boardroom, October.
Play
accepted